Susan G. Komen for the Cure Commits Nearly $58 Million in 2011 to Tackle Toughest Issues with New, Innovative Approaches to Breast Cancer Research

Developing genetic interventions that target the immune system and creating personalized cancer vaccines are just two of more than 80 innovative research grants being funded this year by Susan G. Komen for the Cure. The world’s largest breast cancer organization announced it will fund $55 million toward research grants at 56 institutions across the U.S. and internationally in 2011 and nearly $3 million toward 33 grants to support patient support conferences and programs.